Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium-catalyzed route offers mild conditions and significant cost reduction in pharmaceutical intermediate manufacturing for global supply chains and strategic partners.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel asymmetric oxidative coupling method for chiral spiro indolones using cinchona catalysts. High yield, mild conditions, scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine.
Novel FeCl3-catalyzed route offers high yield and scalability for drug intermediates, reducing costs in API manufacturing.
Novel silver oxide promoted method for high purity imidazole intermediates. Cost effective scalable process ensuring supply chain reliability.
Patent CN115637454A reveals a green electrochemical route for tetrahydroimidazo[1,5-a]quinoxalin-4(5H)-one derivatives, offering cost-effective API intermediate manufacturing.
Novel iodine-catalyzed method for C3-alkylated indoles offers metal-free green synthesis and cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN111675662B reveals a novel iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed route offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing with scalable processes.
Novel nickel-catalyzed method offers cost-effective supply chain solutions for high-purity intermediates without noble metals.
Patent CN107501158A reveals a palladium-catalyzed route for indole derivatives. Achieve cost reduction in fine chemical manufacturing with scalable, high-purity intermediates.
Novel synthesis method for N-N axis chiral compounds offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN112480015B reveals a novel one-pot Pd-catalyzed method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and high purity.
Patent CN110467579B discloses a novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles, offering a cost-effective, metal-free route for pharmaceutical intermediates.
Patent CN102120731A reveals a novel, high-yield route for Gefitinib intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN107522645B details a novel ruthenium-catalyzed [3+2] cycloaddition for polysubstituted pyrroles. This method offers mild conditions and broad substrate scope for pharmaceutical intermediates.
Patent CN109879792B details a Rh(III)-catalyzed oxidative Heck reaction for isoindoles. Offers efficient route for pharmaceutical intermediates manufacturing with improved atom economy.
Novel metal-free route for azaspiro compounds offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally ensuring high purity standards.